Asymmetric multiplex-polymerase chain reaction - A high throughput method for detection and sequencing genomic fusion sites in t(4;11)

British Journal of Haematology

Volumn 124, Issue 1, 2004, Pages 47-54

  Metzler, M ^a,d   Brehm, U ^a   Langer, T ^a   Viehmann, S ^b   Borkhardt, A ^b   Stanulla, M ^c   Schrappe, M ^c   Harbott, J ^b   Beck, J D ^a   Rascher, W ^a   Repp, R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Acute lymphoblastic leukaemia; Chromosomal translocation; Minimal residual disease; Polymerase chain reaction

Indexed keywords

DNA FRAGMENT; DNA MARKER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; ASYMMETRIC MULTIPLEX POLYMERASE CHAIN REACTION; BINDING SITE; BONE MARROW; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 4; CLINICAL ARTICLE; CONTROLLED STUDY; GENOMIC FRAGMENT; GENOMIC FUSION SITE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKEMIA; MINIMAL RESIDUAL DISEASE; NUCLEOTIDE SEQUENCE; PARENTAL CONSENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 4; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TAQ POLYMERASE; TRANSLOCATION, GENETIC;

EID: 9144229115     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04740.x     Document Type: Article

References (31)

1. Betti, C.J., Villalobos, M.J., Diaz, M.O. & Vaughan, A.T. (2001) Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system. Cancer Research, 61, 4550-4555.
2. Biondi, A., Rambaldi, A., Rossi, V., Elia, L., Caslini, C., Basso, G., Battista, R., Barbui, T., Mandelli, F. & Masera, G. (1993) Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. Blood, 82, 2943-2947.
3. Biondi, A., Valsecchi, M.G., Seriu, T., D'Aniello, E., Willemse, M.J., Fasching, K., Pannunzio, A., Gadner, H., Schrappe, M., Kamps, W.A., Bartram, C.R., van Dongen, J.J. & Panzer-Grumayer, E.R. (2000) Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the international BFM study group. Leukemia, 14, 1939-1943.
4. Borkhardt, A., Wuchter, C., Viehmann, S., Pils, S., Teigler-Schlegel, A., Stanulla, M., Zimmermann, M., Ludwig, W.D., Janka-Schaub, G., Schrappe, M. & Harbott, J. (2002) Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia, 16, 1685-1690.
5. Brownie, J., Shawcross, S., Theaker, J., Whitcombe, D., Ferrie, R., Newton, C. & Little, S. (1997) The elimination of primer-dimer accumulation in PCR. Nucleic Acids Research, 25, 3235-3241.
6. Cave, H., van der Werff ten Bosch, J., Suciu, S., Guidal, C., Waterkeyn, C., Otten, J., Bakkus, M., Thielemans, K., Grandchamp, B. & Vilmer, E. (1998) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. New England Journal of Medicine, 339, 591-598.
7. Cimino, G., Elia, L., Rivolta, A., Rapanotti, M.C., Rossi, V., Alimena, G., Annino, L., Canaani, E., Lo, C.F. & Biondi, A. (1996) Clinical relevance of residual disease monitoring by polymerase chain reaction in patients with ALL-1/AF-4 positive-acute lymphoblastic leukaemia. British Journal of Haematology, 92, 659-664.
8. Cimino, G., Elia, L., Rapanotti, M.C., Sprovieri, T., Mancini, M., Cuneo, A., Mecucci, C., Fioritoni, G., Carotenuto, M., Morra, E., Liso, V., Annino, L., Saglio, G., De Rossi, G., Foa, R. & Mandelli, F. (2000) A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia. Blood, 95, 96-101.
9. van Dongen, J.J., Seriu, T., Panzer-Grumayer, E.R., Biondi, A., Pongers-Willemse, M.J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W.A., Gadner, H., Van Wering, E.R., Ludwig, W.D., Basso, G., de Bruijn, M.A., Cazzaniga, G., Hettinger, K., van der Does-van den Berg, A., Hop, W.C., Riehm, H. & Bartram, C.R. (1998) Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet, 352, 1731-1738.
10. van Dongen, J., Macintyre, E.A., Gabert, J., Delabesse, E., Rossi, V., Saglio, G., Gottardi, E., Rambaldi, A., Dotti, G., Griesinger, F., Parreira, A., Gameiro, P., Gonzáles Diáz, M., Malec, M., Langerak, A.W., San Miguel, J.F. & Biondi, A. (1999) Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia fpr detection of minimal residual disease. Leukemia, 13, 1901-1928.
11. Gillert, E., Leis, T., Repp, R., Reichel, M., Hosch, A., Breitenlohner, I., Angermuller, S., Borkhardt, A., Harbott, J., Lampert, F., Griesinger, F., Greil, J., Fey, G.H. & Marschalek, R. (1999) A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells. Oncogene, 18, 4663-4671.
12. Greaves, M. (1999) Molecular genetics, natural history and the demise of childhood leukaemia. European Journal of Cancer, 35, 173-185.
13. Harbott, J. (1998) Cytogenetics in childhood acute lymphoblastic leukemia. Reviews in Clinical and Experimental Hematology, 5, 25-43.
14. Hunger, S.P. & Cleary, M.L. (1998) What significance should we attribute to the detection of MLL fusion transcripts? Blood, 92, 709-711.
15. Janssen, J.W., Ludwig, W.D., Borkhardt, A., Spadinger, U., Rieder, H., Fonatsch, C., Hossfeld, D.K., Harbott, J., Schulz, A.S. & Repp, R. (1994) Pre-pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission. Blood, 84, 3835-3842.
16. Leis, T., Repp, R., Borkhardt, A., Metzler, M., Schlager, F., Harbott, J. & Lampert, F. (1998) A new fingerprint method for sequence analysis of chromosomal translocations at the genomic DNA level. Leukemia, 12, 758-763.
17. Megonigal, M.D., Rappaport, E.F., Jones, D.H., Kim, C.S., Nowell, P.C., Lange, B.J. &Felix, C.A. (1997) Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias. Proceedings of the National Academy of Sciences of the United States of America, 94, 11583-11588.
18. Peham, M., Panzer, S., Fasching, K., Haas, O.A., Fischer, S., Marschalek, R., Gadner, H. & Panzer-Grumayer, E.R. (2002) Low frequency of donotypic Ig and T-cell receptor gene rearrangements in t(4;11) infant acute lymphoblastic leukaemia and its implication for the detection of minimal residual disease. British Journal of Haematology, 117, 315-321.
19. Pongers-Willemse, M.J., Seriu, T., Stolz, F., D'Aniello, E., Gameiro, P., Pisa, P., Gonzalez, M., Bartram, C.R., Panzer-Grumayer, E.R., Biondi, A., San Miguel, J.F. & van Dongen, J.J. (1999) Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia, 13, 110-118.
20. Pui, C.H. (1995) Childhood leukemias. New England Journal of Medicine, 332, 1618-1630.
21. Pui, C.H., Crist, W.M. & Look, A.T. (1990) Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood, 76, 1449-1463.
22. Pui, C.H., Frankel, L.S., Carroll, A.J., Raimondi, S.C., Shuster, J.J., Head, D.R., Crist, W.M., Land, V.J., Pullen, D.J. & Steuber, C.P. (1991) Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. Blood, 77, 440-447.
23. Pui, C.H., Carroll, L.A., Raimondi, S.C., Shuster, J.J., Crist, W.M. & Pullen, D.J. (1994) Childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): an update. Blood, 83, 2384-2385.
24. Rabbitts, T.H. (1994) Chromosomal translocations in human cancer. Nature, 372, 143-149.
25. Raffini, L.J., Slater, D.J., Rappaport, E.F., Lo, N.L., Cheung, N.K., Biegel, J.A., Nowell, P.C., Lange, B.J. & Felix, C.A. (2002) Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6. Proceedings of the National Academy of Sciences of the United States of America, 99, 4568-4573.
26. Reichel, M., Gillert, E., Breitenlohner, I., Repp, R., Greil, J., Beck, J.D., Fey, G.H. & Marschalek, R. (1999) Rapid isolation of chromosomal breakpoints from patients with t(4;ll) acute lymphoblastic leukemia: implications for basic and clinical research. Cancer Research, 59, 3357-3362.
27. Roth, D., Porter, T. & Wilson, J. (1985) Mechanisms of non-homologous recombination in mammalian cells. Molecular and Cellular Biology, 5, 2599-2607.
28. Rowley, J.D. (1998) The critical role of chromosome translocations in human leukemias. Annual Review of Genetics, 32, 495-519.
29. Sichert, P.D., Chenchik, A., Kellogg, D.E., Lukyanov, K.A. & Lukyanov, S.A. (1995) An improved PCR method for walking in uncloned genomic DNA. Nucleic Acids Research, 23, 1087-1088.
30. Uckun, F.M., Herman-Hatten, K., Crotty, M.L., Sensel, M.G., Sather, H.N., Tuel-Ahlgren, L., Sarquis, M.B., Bostrom, B., Nachman, J.B., Steinherz, P.G., Gaynon, P.S. & Heerema, N. (1998) Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood, 92, 810-821.
31. zur-Stadt, U., Harms, D.O., Schluter, S., Schrappe, M., Goebel, U., Spaar, H., Janka, G. & Kabisch, H. (2001) MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen. Leukemia, 15, 283-285.